MedTrace Logo

Real-life Clinical Experience With Ialuadapter Study

NCT06540248 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2024-08-06

No results posted yet for this study

Summary

A retrospective study from a single center was performed. Quantitative and qualitative data was obtained on the use of the syringe adapter (IALUADAPTER®) in 61 patients with IC/BPS (n=48), rUTI (n=6) and mixed /other diagnoses (including OAB; n= 7) who were receiving intravesical therapy. The evaluation period was 6 months during 2018-2019. Reasons for trying the syringe adapter, reasons for continuing with it and occurrence of UTIs before and during the evaluation period were recorded. In addition, 3 year follow-up data were obtained to assess long-term usage of the syringe adapter.

Conditions

  • Interstitial Cystitis, Chronic
  • Overactive Bladder Syndrome
  • Recurrent Urinary Tract Infection

Interventions

DEVICE

Ialuadapter

minimally invasive syringe device for bladder catherization

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06540248 on ClinicalTrials.gov